Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001969223-24-000492
Filing Date
2024-06-20
Accepted
2024-06-20 16:28:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5897
  Complete submission text file 0001969223-24-000492.txt   7453
Mailing Address OSI PHARMACEUTICALS, INC. 41 PINELAWN ROAD MELVILLE NY 11747
Business Address
Epstein David M. (Reporting) CIK: 0001488668 (see all company filings)

Type: 144

Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Subject) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39200 | Film No.: 241056663
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)